GlassScriptPhysician profile
Bothwell D Lee
NPI 1043320252
$976.78
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $79.06 · 2021: $255 · 2022: $140 · 2023: $35.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $204.25 | 2019-2020 | |
| Abbott Laboratories | $158.67 | 2019-2021 | |
| Amgen INC. | $142.52 | 2019-2020 | |
| Varian Medical Systems, INC. | $111.34 | 2019 | |
| Lundbeck LLC | $69.63 | 2021-2022 | |
| Lilly USA, LLC | $54.93 | 2021-2022 | |
| Abbvie INC. | $48.08 | 2021-2023 | |
| Eisai INC. | $22.05 | 2022 | |
| Acorda Therapeutics, INC | $21.89 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.39 | 2022 | |
| Genentech USA, INC. | $21.08 | 2021 | |
| Shire North American Group INC | $20.79 | 2019 | |
| Genzyme Corporation | $18.80 | 2019 | |
| Emd Serono, INC. | $18.53 | 2021 | |
| Biogen, INC. | $15.65 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $15.16 | 2021 | |
| Livanova USA, INC. | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bothwell Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.